Eli Lilly and Company (LLY) Eli Lilly (NYSE: LLY) To Provide Additional Doses Of Neutralizing Antibody Therapy To US Eli Lilly and Company (NYSE: LLY) disclosed that the US government has informed the firm that authorities will buy at least 100,000 doses of bamlanivimab 700 mg and etesevimab 1400 mg together.